SCHEMBL23064677

SCHEMBL23064677

O=C(c1c[nH]c2ccccc12)[C@@H](NCCN1CCCCC1=O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HAT1 O14929 20/20 0.60
EP300 Q09472 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21282561 1.00 HAT1 (0.60) HAT1EP300
SCHEMBL29820972 1.00 HAT1 (0.60) HAT1EP300
SCHEMBL23040426 1.00 HAT1 (0.60) HAT1EP300
SCHEMBL21530819 0.80 HAT1 (0.60) HAT1EP300
SCHEMBL14832921 0.80 HAT1 (0.60) HAT1EP300
SCHEMBL21282442 0.79 HAT1 (0.60) HAT1EP300
SCHEMBL23040409 0.79 HAT1 (0.60) HAT1EP300
SCHEMBL29820798 0.79 HAT1 (0.60) HAT1EP300
SCHEMBL21282443 0.79 HAT1 (0.60) HAT1EP300
SCHEMBL23040507 0.76 EP300 (0.87) HAT1EP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210061762-A1 P300/CBP HAT INHIBITORS CONSTELLATION PHARMACEUTICALS, INC. 2021-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210061762-A1 P300/CBP HAT INHIBITORS EP300, HDAC1, KAT2A HAT1 8/4885EP300 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.